These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25049046)
41. Correspondence on 'Long-term efficacy and safety of canakinumab in patients with colchicine-resistant familial Mediterranean fever: results from the randomised phase III CLUSTER trial'. Satış H; Aydemir E; İzmirlioğlu K; Tufan A Ann Rheum Dis; 2022 Dec; 81(12):e256. PubMed ID: 32988847 [No Abstract] [Full Text] [Related]
42. [THE CERTAIN CLINICAL CHARACTERISTICS OF BLOOD IN PATIENTS WITH FAMILY MEDITERRANEAN FEVER OF ARMENIAN POPULATION]. Pepoian AZ; Arutunian N; Grigorian A; Tsaturian VV; Manvelian AM; Dilnian E; Balaian MA; Torok T Klin Lab Diagn; 2015 Jun; 60(6):46-7. PubMed ID: 26466452 [TBL] [Abstract][Full Text] [Related]
43. Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome. Torene R; Nirmala N; Obici L; Cattalini M; Tormey V; Caorsi R; Starck-Schwertz S; Letzkus M; Hartmann N; Abrams K; Lachmann H; Gattorno M Ann Rheum Dis; 2017 Jan; 76(1):303-309. PubMed ID: 27474763 [TBL] [Abstract][Full Text] [Related]
44. Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation. Moser C; Pohl G; Haslinger I; Knapp S; Rowczenio D; Russel T; Lachmann HJ; Lang U; Kovarik J Nephrol Dial Transplant; 2009 Feb; 24(2):676-8. PubMed ID: 19033248 [TBL] [Abstract][Full Text] [Related]